Significantly upregulated pathways in IBD included inflammatory response, interferon-α and interferon-γ responses, IL6-JAK-STAT3 signaling, TNF-α signaling via NF-κB, and complement activation, reflecting the chronic inflammatory nature of IBD. Here, STAT3 is linked to inflammatory bowel disease.